Diagnostics device for rapid identification and antibiotics susceptibility testi...
Diagnostics device for rapid identification and antibiotics susceptibility testing of pathogens
Biotrack is a SME focused on the development and commercialization of novel microbial detection technology to achieve real time and actionable diagnostics. Our technology is covered with a solid patent portfolio.
We have identifi...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MAGTEST
MAGTEST Simple and specific next generation lab on a chip i...
71K€
Cerrado
RAPID
Rapid Antimicrobial susceptibility testing and phylogenetic...
150K€
Cerrado
ResisTEST
Developing a rapid diagnostic kit for antibiotic resistance
150K€
Cerrado
AntibioDx
AntibioDx A groundbreaking in vitro diagnostic device with...
71K€
Cerrado
Molecular Culture
World’s first diagnostic test that can detect all bacterial...
5M€
Cerrado
Información proyecto Biotrack-MED
Duración del proyecto: 4 meses
Fecha Inicio: 2019-07-21
Fecha Fin: 2019-11-30
Líder del proyecto
BIOTRACK BV
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Biotrack is a SME focused on the development and commercialization of novel microbial detection technology to achieve real time and actionable diagnostics. Our technology is covered with a solid patent portfolio.
We have identified a high market need for new pathogen detection techniques due to 2 main reasons: A) Dependency on standard microbiological protocols might delay early diagnosis; B) Growing demand for research and innovation, and a better quality and patient-centered technology due to the dramatic spread of antibiotic-resistant infections.
Biotrack's innovative solution, Biotrack-MED, is a micro-laboratory capability solution for the rapid detection, identification and antibiotic susceptibility testing of pathogens in any biological sample. Biotrack-MED is a fast and effective user-adaptable solution that combines multiple analytical principles for microbial identification and antibiotic pre-screening (total operative time: 0,5-4 hours), and it's capable of analyzing any microorganism (bacteria, virus, yeast). Our solution can be placed anywhere (includes a complementary mobile app) and it is equipped with state-of-the-art privacy and decision-making tools. Biotrack-MED offers a cost-effective low-cost substitution (50% saving) of traditional laboratories, and it does not require any skilled personnel to be used.
Considering the advantages of our unique healthcare solution, our expected customers in the EU are public and private hospitals and clinics. We have estimated that 5 years after start of commercialization we will reach a ROI of 5.8.